Anti-Inflammatory and CNS dEpressant Properties of 1-(4-chlorophenyl)-4-{2-[3-(2-pyridyl) acrylyloxy]-ethyl}-piperazine (DA 1529)

Crescenzi, 1966, J. Pharm. Sci., 55, 290, 10.1002/jps.2600550306

Winter, 1962, Proc. Soc. Exptl. Biol. Med., 111, 544, 10.3181/00379727-111-27849

Niemegeers, 1964, J. Pharm. Pharmacol., 16, 810, 10.1111/j.2042-7158.1964.tb07414.x

Litchfield, 1949, J. Pharmacol. Exptl. Therap., 96, 99

Burn, 1952, 48

Irwin, 1964, 36

Marazzi-Uherti, E., and Turba, C., Arch. Intern. Pharmacodyn., to be publisherd.

Smith, 1935, J. Pharmacol. Exptl. Therap., 54, 346

Randall, 1957, Arch. Intera. Pharmacodyn., 111, 109

Marazzi-Uherti, E., Turba, C., and Erba, G., Arch. Intera. Pharmacodyn. to be published.

Dews, 1953, Brit. J. Pharmacol., 8, 46

Boissier, 1959, Actualités Pharmacologiques, 12, 7

Randall, 1960, J. Pharmacol. Exptl. Therap., 129, 168

Berger, 1948, J. Pharmacol. Exptl. Therap., 93, 470

Witkin, 1960, Toxicol. Appl. Pharmacol., 2, 264, 10.1016/0041-008X(60)90056-9

Setnikar, 1956, Farmaco Pavia(Ed. Sci.), 11, 750

Lessin, 1957, Brit. J. Pharmacol., 12, 245

Lenie, 1961, J. Pharm. Pharmarol., 13, 734, 10.1111/j.2042-7158.1961.tb11900.x

1963, J. Pharm. Pharmarol., 15, 454, 10.1111/j.2042-7158.1963.tb12813.x

Lessin, 1957, J. Pharm. Pharmarol., 9, 657, 10.1111/j.2042-7158.1957.tb12321.x

Davison, 1957, Experientia, 13, 329, 10.1007/BF02296828

Askew, 1963, Life Sciences., 10, 725, 10.1016/0024-3205(63)90076-6

Richter, 1961, Acta Pharmacol. Toxicol., 21, 91, 10.1111/j.1600-0773.1964.tb01771.x